Veronique Lecault - 08 Dec 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Operating Officer, Director
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
08 Dec 2021
Net transactions value
+$47,500
Form type
4
Filing time
09 Dec 2021, 16:49:52 UTC
Previous filing
09 Dec 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Options Exercise $47,500 +250,000 +19% $0.1900* 1,589,333 08 Dec 2021 Direct
holding ABCL Common Shares 7,155,008 08 Dec 2021 See Footnote F1
holding ABCL Common Shares 273,630 08 Dec 2021 See Footnote F2
holding ABCL Common Shares 61,580 08 Dec 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share Option (right to buy) Options Exercise $0 -250,000 -9% $0.000000 2,524,134 08 Dec 2021 Common Shares 250,000 $0.1900 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
F2 These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
F3 The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.